AbCellera to Present at Jefferies Global Healthcare Conference in London
1 report, 1 independent
Updated Oct 22
AI-generated briefing. Brind wrote this from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
AbCellera announced it will present at two investor conferences. One is the Stifel Healthcare Conference on November 11, 2026, and the other is the Jefferies Global Healthcare Conference in London on November 16, 2026. AbCellera is a clinical-stage biotechnology company focused on developing antibody-based medicines in various therapeutic areas.
From northernnews.ca
Why it matters
As a clinical-stage biotechnology company, AbCellera's presentations could influence investor perception regarding the progress and commercialization potential of its drug pipeline. The company is engaged in strategic collaborations with Jazz Pharmaceuticals and Vertex to develop new treatments.
From northernnews.ca